美国 · 平台与数据 · Stocktwits
Biotech Dealmaker: Early-Stage Platforms And Tools Draw Capital As Full Buyouts Remain On The Sidelines This Week
详细摘要
Large drugmakers and specialized investors continued to favor targeted capability additions, asset purchases, and co-funding arrangements over outright buyouts of late-stage…
MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (stocktwits.com)
